To elucidate the relationship between malignant transformation and cyt
okine receptor expression, the interleukin-3 receptor (IL-3R) complex
was examined in an IL-3-dependent parental line and cells transformed
by cytokines and oncogenes. In IL-3-dependent cells grown in medium co
ntaining optimum amounts of IL-3, the IL-3R complex was detected at lo
w levels indicating that the receptor was down-regulated in response t
o IL-3. However, upon depletion of IL-3, IL-3R levels increased docume
nting that its expression correlated inversely with the concentration
of IL-3 provided. In contrast, more IL-3 receptors were observed const
itutively in autocrine-transformed derivative lines, which secreted su
boptimal amounts of IL-3. To examine the effects of activated oncogene
s on IL-3R expression in autocrine-transformed cells, the cells were i
nfected with retroviral vectors containing various oncogenes. Decrease
d levels of IL-3R expression were observed in the oncogene-infected ce
lls. These studies imply that important regulatory cross-talk occurs b
etween ligands and their cognate receptors in cytokine-dependent hemat
opoietic cells. Deregulation of this ligand-receptor interaction in th
e oncogene-infected cells may be a consequence of the cells using modi
fied signal transduction pathways which bypass the IL-3:IL-3R interact
ion. To determine the effects of IL-3 receptor overexpression on the c
ytokine dependency of hematopoietic cells, IL-3R alpha and beta cDNAs
were inserted into retroviral vectors. Overexpression of either the al
pha or beta chains did not directly relieve factor dependency, however
, constitutive expression of the IL-3R alpha allowed the cells to prol
iferate in suboptimal concentrations of IL-3. Moreover, factor-indepen
dent transformants were subsequently isolated from pools of cells infe
cted with viruses containing either the alpha or beta receptor cDNAs a
t a frequency of approximately 1 in 10(3) to 10(4) cells whereas such
cells were not recovered from control cells. Deregulation of IL-3 rece
ptor chain gene expression may provide a proliferative advantage to he
matopoietic cells growing under conditions in which the cytokine is li
miting and allow the development of a leukemia.